Analyst Price Targets — LPCN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 13, 2026 6:08 pm | — | Industrial Alliance Securities | $6.00 | $2.38 | TheFly | Lipocine price target lowered to $6 from $11 at Alliance Global |
| January 21, 2026 11:12 am | — | H.C. Wainwright | $15.00 | $9.92 | TheFly | Lipocine price target raised to $15 from $7 at H.C. Wainwright |
| September 24, 2024 8:11 am | Scott Henry | Industrial Alliance Securities | $10.00 | $4.54 | TheFly | Lipocine initiated with a Buy at Alliance Global Partners |
Latest News for LPCN
Study informed by encouraging exploratory efficacy findings and a favorable safety profile in the prior Phase 3 trial Approximately 120 participants with severe postpartum depression (PPD) planned; first participant dosing expected in early Q4 2026 Company expects existing resources to support BLOOM SALT LAKE CITY, Sept. 14, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company…
SALT LAKE CITY, Sept. 10, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that Company management will present and meet with investors at the H.C.
SALT LAKE CITY, Aug. 4, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced financial results for the second quarter ended June 30, 2026 and provided a corporate update. Recent Developments and Corporate Update LPCN 1154 (BRLIZIO™) for Postpartum Depression (PPD) On April 2, 2026, Lipocine reported topline…
SALT LAKE CITY, Aug. 3, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced the appointment of Michael J. Grissinger to its Board of Directors, effective August 3, 2026.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for LPCN.
U.S. House Trading
No House trades found for LPCN.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.